IA
HAE icon

Icon Advisers’s Haemonetics HAE Stock Holding History

Icon Advisers’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-35,000
Closed -$1.14M – 349
2014
Q1 		$1.14M Hold
35,000
– – 0.08% 185
2013
Q4 		$1.48M Buy
35,000
+11,000
+46% +$453K 0.11% 149
2013
Q3 		$957K Buy
+24,000
New +$1.01M 0.07% 201

Other funds holding HAE

Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Icon Advisers's HAE Position: Q2 2014 in Review

Icon Advisers sold out of Haemonetics (HAE) in Q2 2014, closing a stake of 35,000 shares — an estimated $1.14M sold.

Icon Advisers first reported a position in HAE in Q3 2013 and held it in 3 quarters. The position peaked at $1.48M in Q4 2013. 175 funds tracked by Wall St. Rank hold HAE as of Q2 2014.

  • Icon Advisers reported no remaining Haemonetics position as of Q2 2014 after selling out during the quarter.
  • Icon Advisers sold 35,000 Haemonetics shares in Q2 2014, an estimated $1.14M.
  • Icon Advisers first reported a position in Haemonetics in Q3 2013 and held it in 3 quarters.
  • Icon Advisers's Haemonetics position peaked at $1.48M in Q4 2013.
  • 175 funds tracked by Wall St. Rank held Haemonetics as of Q2 2014.

Based on Icon Advisers's 13F filing for Q2 2014, filed 6 Aug 2014.